AVIRULENT SALMONELLA EXPRESSING HYBRID HEPATITIS-B VIRUS CORE/PRE-S GENES FOR ORAL VACCINATION

被引:11
作者
SCHODEL, F
PETERSON, D
HUGHES, J
MILICH, DR
机构
[1] MAX PLANCK INST BIOCHEM, W-8033 MARTINSRIED, GERMANY
[2] SCRIPPS RES INST, LA JOLLA, CA USA
[3] VIRGINIA COMMONWEALTH UNIV, DEPT BIOCHEM, RICHMOND, VA 23284 USA
关键词
HEPATITIS-B VIRUS; CORE PARTICLES; B-CELL EPITOPES; SALMONELLA;
D O I
10.1016/0264-410X(93)90010-U
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This report reviews and extends data on the use of hepatitis B virus (HBV) core (HBcAg) particles as a carrier moiety for B-cell epitopes of the HBV envelope proteins1-4. Virus-neutralizing epitopes of the HBV pre-S region were inserted at the N-terminus, the N-terminus through a precore linker sequence, the C-terminus and an internal position of HBcAg by genetic engineering in Escherichia coli. The hybrid HBc/pre-S proteins were purified and their antigenicity and immunogenicity analysed. All purified HBc/pre-S particles were particulate. Pre-S epitopes inserted at the N-terminus through a precore polylinker, the truncated C-terminus and at the internal position between HBcAg amino acids 75 and 81 were accessible on the particle surface. N-terminal fusions required the presence of the linker sequence to become surface accessible and immunogenic. Fusions to the N- and C-termini of HBcAg did not interfere with HBcAg antigenicity and immunogenicity. In contrast, insertion al the internal site abrogated recognition of HBcAg by five out of six monoclonal antibodies and diminished recognition by human polyclonal anti-HBc antibodies as well as HBcAg immunogenicity. A pre-S(2) sequence fused to the C-terminus of HBcAg was surface accessible and weakly immunogenic. Pre-S(1) sequences fused to the N-terminus through a precore linker were surface accessible and highly immunogenic. The same sequence fused to the core methionine was not surface accessible or immunogenic. Insertion of the same pre-S(1) sequence at an internal position of HBcAg resulted in the most efficient anti-pre-S(1) antibody response. Hybrid HBc/pre-S particles were also expressed in avirulent aroA or DELTAcya DELTAcrp Salmonella typhimurium and Salmonella dublin. Oral immunization of mice with Salmonella expressing C-terminally fused hybrid HBc/pre-S(2) particles resulted in high-titred serum anti-HBc antibodies and low-titred anti-pre-S(2) antibodies. Oral immunization with DELTAcya DELTAcrp S. typhimurium expressing internally fused HBc/pre-S hybrid elicited high titred serum anti-pre-S(1) antibodies.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 26 条
[1]   RECOMBINANT CORE PARTICLES OF HEPATITIS-B VIRUS EXPOSING FOREIGN ANTIGENIC DETERMINANTS ON THEIR SURFACE [J].
BORISOVA, GP ;
BERZINS, I ;
PUSHKO, PM ;
PUMPEN, P ;
GREN, EJ ;
TSIBINOGIN, VV ;
LOSEVA, V ;
OSE, V ;
ULRICH, R ;
SIAKKOU, H ;
ROSENTHAL, HA .
FEBS LETTERS, 1989, 259 (01) :121-124
[2]  
CLARKE BE, 1991, VACCINES 91, P313
[3]   IMPROVED IMMUNOGENICITY OF A PEPTIDE EPITOPE AFTER FUSION TO HEPATITIS-B CORE PROTEIN [J].
CLARKE, BE ;
NEWTON, SE ;
CARROLL, AR ;
FRANCIS, MJ ;
APPLEYARD, G ;
SYRED, AD ;
HIGHFIELD, PE ;
ROWLANDS, DJ ;
BROWN, F .
NATURE, 1987, 330 (6146) :381-384
[4]   SALMONELLA-TYPHIMURIUM DELETION MUTANTS LACKING ADENYLATE-CYCLASE AND CYCLIC-AMP RECEPTOR PROTEIN ARE AVIRULENT AND IMMUNOGENIC [J].
CURTISS, R ;
KELLY, SM .
INFECTION AND IMMUNITY, 1987, 55 (12) :3035-3043
[5]  
CURTISS R, 1990, NEW GENERATION VACCI, P161
[6]   HEPATIC EXPRESSION PATTERNS OF THE LARGE AND MIDDLE HEPATITIS-B VIRUS SURFACE-PROTEINS IN VIREMIC AND NONVIREMIC CHRONIC HEPATITIS-B [J].
DIENES, HP ;
GERLICH, WH ;
WORSDORFER, M ;
GERKEN, G ;
BIANCHI, L ;
HESS, G ;
ZUMBUSCHENFELDE, KHM .
GASTROENTEROLOGY, 1990, 98 (04) :1017-1023
[7]   AROMATIC-DEPENDENT SALMONELLA-TYPHIMURIUM ARE NON-VIRULENT AND EFFECTIVE AS LIVE VACCINES [J].
HOISETH, SK ;
STOCKER, BAD .
NATURE, 1981, 291 (5812) :238-239
[8]  
IWARSON S, 1985, GASTROENTEROLOGY, V88, P763, DOI 10.1016/0016-5085(85)90148-9
[9]   THE NUCLEOCAPSID OF HEPATITIS-B VIRUS IS BOTH A T-CELL INDEPENDENT AND A T-CELL-DEPENDENT ANTIGEN [J].
MILICH, DR ;
MCLACHLAN, A .
SCIENCE, 1986, 234 (4782) :1398-1401
[10]  
MILICH DR, 1987, J IMMUNOL, V139, P1223